Esmail Rayatdoost
Overview
Explore the profile of Esmail Rayatdoost including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rayatdoost E, Chegin M, Taghipour A, Shadmand E, Rezaei F, Falahi S, et al.
PLoS One
. 2024 Aug;
19(8):e0307950.
PMID: 39172983
Background: Road traffic injuries (RTIs) are among the most important issues worldwide. Several studies reported that infection with the neurotropic parasite Toxoplasma gondii (T. gondii) increased the risk of car...
2.
Rayatdoost E, Rahmanian M, Sanie M, Rahmanian J, Matin S, Kalani N, et al.
Yale J Biol Med
. 2022 Jul;
95(2):221-235.
PMID: 35782481
: The emergence of the novel Coronavirus Disease 2019 (COVID-19) sparked an unprecedented effort to develop effective vaccines against the disease. Some factors may boost the vaccine efficacy, including sufficient...
3.
Taghipour A, Rayatdoost E, Bairami A, Bahadory S, Abdoli A
Infect Agent Cancer
. 2022 Jun;
17(1):32.
PMID: 35715853
Objective: Intestinal protozoa Blastocystis hominis and Cryptosporidium spp. are two influential factors in intestinal complications and malignancies. In present study, we estimated the pooled prevalence and odds ratio (OR) of...
4.
Abiri S, Chegin M, Soleimani R, Hatami N, Kalani N, Rayatdoost E
Arch Acad Emerg Med
. 2022 Apr;
10(1):e19.
PMID: 35402989
Introduction: Acute headache is one of the most common reasons for emergency department (ED) visits. This study aimed to compare the combination of propofol and granisetron with propofol and metoclopramide...